Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.96% | 28.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.08% | 3.99% | |||
| Operating Income | -7.08% | -3.99% | |||
| Income Before Tax | -10.07% | -6.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.07% | -6.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.07% | -6.47% | |||
| EBIT | -7.08% | -3.99% | |||
| EBITDA | -7.12% | -3.94% | |||
| EPS Basic | -9.56% | -6.15% | |||
| Normalized Basic EPS | -9.57% | -6.16% | |||
| EPS Diluted | -9.56% | -6.15% | |||
| Normalized Diluted EPS | -9.57% | -6.16% | |||
| Average Basic Shares Outstanding | 0.47% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||